Brown PH - Search Results

1

Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.

Medina D, Kittrell F, Hill J, Zhang Y, Hilsenbeck SG, Bissonette R, Brown PH. Medina D, et al. Among authors: brown ph. Cancer Prev Res (Phila). 2009 Feb;2(2):168-74. doi: 10.1158/1940-6207.CAPR-08-0107. Epub 2009 Jan 27. Cancer Prev Res (Phila). 2009. PMID: 19174577 Free PMC article.

2

Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.

Wu K, Kim HT, Rodriquez JL, Hilsenbeck SG, Mohsin SK, Xu XC, Lamph WW, Kuhn JG, Green JE, Brown PH. Wu K, et al. Among authors: brown ph. Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):467-74. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12010861

3

Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.

Liu Y, Ludes-Meyers J, Zhang Y, Munoz-Medellin D, Kim HT, Lu C, Ge G, Schiff R, Hilsenbeck SG, Osborne CK, Brown PH. Liu Y, et al. Among authors: brown ph. Oncogene. 2002 Oct 31;21(50):7680-9. doi: 10.1038/sj.onc.1205883. Oncogene. 2002. PMID: 12400010

4

The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice.

Wu K, Zhang Y, Xu XC, Hill J, Celestino J, Kim HT, Mohsin SK, Hilsenbeck SG, Lamph WW, Bissonette R, Brown PH. Wu K, et al. Among authors: brown ph. Cancer Res. 2002 Nov 15;62(22):6376-80. Cancer Res. 2002. PMID: 12438218

5

Effect of epidermal growth factor receptor inhibitor on development of estrogen receptor-negative mammary tumors.

Lu C, Speers C, Zhang Y, Xu X, Hill J, Steinbis E, Celestino J, Shen Q, Kim H, Hilsenbeck S, Mohsin SK, Wakeling A, Osborne CK, Brown PH. Lu C, et al. Among authors: brown ph. J Natl Cancer Inst. 2003 Dec 17;95(24):1825-33. doi: 10.1093/jnci/djg117. J Natl Cancer Inst. 2003. PMID: 14679152

6

Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes.

DeNardo DG, Kim HT, Hilsenbeck S, Cuba V, Tsimelzon A, Brown PH. DeNardo DG, et al. Among authors: brown ph. Mol Endocrinol. 2005 Feb;19(2):362-78. doi: 10.1210/me.2004-0267. Epub 2004 Oct 28. Mol Endocrinol. 2005. PMID: 15514030

7

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer.

Allred DC, Brown P, Medina D. Allred DC, et al. Breast Cancer Res. 2004;6(6):240-5. doi: 10.1186/bcr938. Epub 2004 Sep 22. Breast Cancer Res. 2004. PMID: 15535853 Free PMC article. Review.

8

Defining the role of raloxifene for the prevention of breast cancer.

Kalidas M, Hilsenbeck S, Brown P. Kalidas M, et al. J Natl Cancer Inst. 2004 Dec 1;96(23):1731-3. doi: 10.1093/jnci/djh345. J Natl Cancer Inst. 2004. PMID: 15572750 No abstract available.

9

The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.

Kong G, Kim HT, Wu K, DeNardo D, Hilsenbeck SG, Xu XC, Lamph WW, Bissonnette R, Dannenberg AJ, Brown PH. Kong G, et al. Among authors: brown ph. Cancer Res. 2005 Apr 15;65(8):3462-9. doi: 10.1158/0008-5472.CAN-03-2912. Cancer Res. 2005. PMID: 15833882

10

Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis.

Medina D, Kittrell FS, Hill J, Shepard A, Thordarson G, Brown P. Medina D, et al. Cancer Res. 2005 Apr 15;65(8):3493-6. doi: 10.1158/0008.5472.CAN-04-3869. Cancer Res. 2005. PMID: 15833886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters